HomeBGLC • NASDAQ
add
BioNexus Gene Lab Corp
Previous close
$0.43
Day range
$0.43 - $0.46
Year range
$0.32 - $3.39
Market cap
7.93M USD
Avg Volume
735.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 1.97M | -23.07% |
Operating expense | 29.55K | -95.17% |
Net income | 199.10K | 176.80% |
Net profit margin | 10.08 | 199.80% |
Earnings per share | — | — |
EBITDA | 279.37K | 211.08% |
Effective tax rate | 21.82% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.41M | 207.85% |
Total assets | 11.14M | 41.03% |
Total liabilities | 1.59M | -17.63% |
Total equity | 9.55M | — |
Shares outstanding | 17.97M | — |
Price to book | 0.79 | — |
Return on assets | 5.81% | — |
Return on capital | 6.64% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 199.10K | 176.80% |
Cash from operations | -670.54K | -2,714.67% |
Cash from investing | 83.06K | 2,816.22% |
Cash from financing | 173.58K | 7,234.40% |
Net change in cash | -418.15K | -94.91% |
Free cash flow | -680.07K | -501.38% |
About
Founded
2017
Website
Employees
30
